In one of the first Eastern District of Texas interpretations of the Hatch-Waxman Act, the federal law governing the procedure for bringing generic drugs to market, brand-name drug company Allergan Inc. has prevailed against five generic drug makers. U.S. District Judge T. John Ward ruled that the four Allergan patents were valid.
August 29, 2011 at 12:00 AM
1 minute read
In one of the first Eastern District of Texas interpretations of the Hatch-Waxman Act, the federal law governing the procedure for bringing generic drugs to market, brand-name drug company Allergan Inc. has prevailed against five generic drug makers.
On Aug. 22 in Allergan Inc. v. Sandoz Inc ., U.S. District Judge T. John Ward ruled that the four Allergan patents were valid and that the four defendants in the consolidated case had infringed upon it.
Presented by BigVoodoo
Join General Counsel and Senior Legal Leaders at the Premier Forum Designed For and by General Counsel from Fortune 1000 Companies
This event shines a spotlight on the individuals, teams, projects and organizations that are changing the financial industry.
BTI provides leading tax professionals from financial institutions with unmatched tools and resources.
Our client, a small but highly sophisticated and entrepreneurial tax boutique in Charleston, SC, has asked for our firm s assistance in iden...
CORE RESPONSIBILITIES AND TASKS:(1) Tasks and responsibilities include:Reviewing and negotiating commercial agreements for internal business...
Boutique midtown Manhattan law firm specializing in sophisticated real estate litigation & representation of commercial and residential ...
